LIBERTY met all primary/secondary endpoints, with lower 6-day TEAEs/ISRs/hypersensitivity (56.5% vs 91.4%) and systemic AEs ...

Michael Mina, MD, PhD, explains LIBERTY trial findings on VYD2311 tolerability alone and given with an mRNA COVID-19 vaccine.

VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and ...

LIBERTY is a Phase 3, randomized, double-blind clinical trial to evaluate the safety, serum virus neutralizing antibody responses, and pharmacokinetics of VYD2311, an mRNA COVID vaccine, and ...

New research in the February 2022 issue of Journal of the National Comprehensive Cancer Network (JNCCN) confirms that mRNA vaccines for COVID-19 are just as safe for people with cancer as they are for ...

UC Davis Health is offering 2026–27 flu and COVID-19 vaccines. This guide explains who should get them and how to schedule appointments.

VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and tolerability that is clinically and statistically superior to the ...

Comirnaty is an mRNA vaccine that delivers genetic instructions for the SARS-CoV-2 spike protein, prompting the immune system to recognize and respond to the virus, as described by the US Centers for ...

Phase IIa study of tosposertib, a dual TGFβRI and VEGFR2 inhibitor, in combination with pembrolizumab in recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). This is an ASCO ...

Tom has a Master's degree in Journalism. His editorial work covers anything from archaeology and the environment to technology and culture. Tom has a Master's degree in Journalism. His editorial work ...

The answer may lie in what mRNA does inside the immune system. Covid-19 mRNA vaccines deliver genetic instructions that allow ...